Skip to content

InnoRehab: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

InnoRehab

BE 0761.446.337
NACE 46.460, Wholesale of pharmaceutical and medical goods
financial year 2025 compared with 2024filed annual accounts (NBB)
Net result for the year
-€98,995
2024 · -€202,102+€103,107
Equity
€12,297
2024 · -€7,200+€19,497
Cash
€78,527
2024 · €74,215+€4,312
Balance sheet total
€175,496
2024 · €162,405+€13,091

Largest movements

2024 to 2025
Assets
  • Stocks and contracts +€17,454

    up €17,454 (+55.5%), from €31,438 to €48,892

  • Intangible fixed assets -€10,611

    down €10,611 (-46.9%), from €22,630 to €12,019

  • Cash +€4,312

    up €4,312 (+5.8%), from €74,215 to €78,527

    mainly Contributions, distributions and other (+€118,492) and Trade debts (+€13,923)

  • Receivables within one year +€2,168

    up €2,168 (+6.9%), from €31,530 to €33,698

    of which Other amounts receivable: +€9,399

  • Financial fixed assets -€1,880

    down €1,880 (-94.0%), from €2,000 to €120

Equity and liabilities
  • Contributions +€120,800

    up €120,800 (+20.3%), from €595,922 to €716,722

  • Profit (loss) carried forward -€98,996

    down €98,996 (-16.3%), from -€606,253 to -€705,249

  • Debts after one year -€31,387

    down €31,387 (-41.8%), from €75,175 to €43,788

  • Trade debts +€13,923

    up €13,923 (+30.2%), from €46,159 to €60,082

  • Tax, wage and social debts +€10,377

    up €10,377 (+73.8%), from €14,065 to €24,442

    of which Remuneration and social security: +€10,450

Income statement
  • Gross operating margin +€108,246

    up €108,246 (+74.5%), from -€145,383 to -€37,137

  • Staff costs +€7,286

    up €7,286 (+18.0%), from €40,438 to €47,724

  • Financial income -€1,701

    down €1,701 (-37.2%), from €4,577 to €2,876

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 -€202,102
Gross operating margin +€108,246
Staff costs -€7,286
Depreciation +€1,271
Other operating charges +€1,373
Financial income -€1,701
Financial charges +€1,204
Result 2025 -€98,995
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations -€85,765
Investment +€1,881
Financing +€88,196
Cash 2024 €74,215
Net result for the year -€98,995
Depreciation +€10,610
Stocks and contracts -€17,454
Receivables within one year -€2,168
Deferred charges and accrued income -€1,648
Trade debts +€13,923
Tax, wage and social debts +€10,377
Advances received -€299
Smaller working-capital items -€110
Investment in fixed assets (net) +€1,881
Debts after one year -€31,387
Current portion of long-term debt +€1,091
Contributions, distributions and other +€118,492
Cash 2025 €78,527
brings cash intakes cash out
Every line side by side 42 lines
Line Code 2024 2025 Change %
Total assets 20/58 €162,405 €175,496 +€13,091 +8.1%
Fixed assets 21/28 €24,630 €12,139 -€12,491 -50.7%
Intangible fixed assets 21 €22,630 €12,019 -€10,611 -46.9%
Financial fixed assets 28 €2,000 €120 -€1,880 -94.0%
Current assets 29/58 €137,775 €163,357 +€25,582 +18.6%
Stocks and contracts in progress 3 €31,438 €48,892 +€17,454 +55.5%
Stocks 30/36 €31,438 €48,892 +€17,454 +55.5%
Amounts receivable within one year 40/41 €31,530 €33,698 +€2,168 +6.9%
Trade receivables 40 €30,796 €23,565 -€7,231 -23.5%
Other amounts receivable 41 €734 €10,133 +€9,399 +1,281%
Cash at bank and in hand 54/58 €74,215 €78,527 +€4,312 +5.8%
Deferred charges and accrued income 490/1 €592 €2,240 +€1,648 +278%
Total equity and liabilities 10/49 €162,405 €175,496 +€13,091 +8.1%
Equity 10/15 -€7,200 €12,297 +€19,497
Contributions 10/11 €595,922 €716,722 +€120,800 +20.3%
Profit (loss) carried forward 14 -€606,253 -€705,249 -€98,996 -16.3%
Investment grants 15 €3,131 €825 -€2,306 -73.7%
Amounts payable 17/49 €169,605 €163,199 -€6,406 -3.8%
Amounts payable after more than one year 17 €75,175 €43,788 -€31,387 -41.8%
Financial debts 170/4 €75,175 €43,788 -€31,387 -41.8%
Amounts payable within one year 42/48 €94,204 €119,411 +€25,207 +26.8%
Current portion of amounts payable after more than one year 42 €32,866 €33,957 +€1,091 +3.3%
Trade debts 44 €46,159 €60,082 +€13,923 +30.2%
Suppliers 440/4 €46,159 €60,082 +€13,923 +30.2%
Advances received on contracts in progress 46 €299 - -€299
Taxes, remuneration and social security 45 €14,065 €24,442 +€10,377 +73.8%
Taxes 450/3 €3,764 €3,691 -€73 -1.9%
Remuneration and social security 454/9 €10,301 €20,751 +€10,450 +101%
Other amounts payable 47/48 €815 €931 +€116 +14.2%
Accrued charges and deferred income 492/3 €226 - -€226
Remuneration, social security and pensions 62 €40,438 €47,724 +€7,286 +18.0%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €11,881 €10,610 -€1,271 -10.7%
Other operating charges 640/8 €5,205 €3,832 -€1,373 -26.4%
Gross operating margin 9900 -€145,383 -€37,137 +€108,246 +74.5%
Operating profit (loss) 9901 -€202,907 -€99,304 +€103,603 +51.1%
Financial income 75/76B €4,577 €2,876 -€1,701 -37.2%
Recurring financial income 75 €4,577 €2,876 -€1,701 -37.2%
Financial charges 65/66B €3,772 €2,568 -€1,204 -31.9%
Recurring financial charges 65 €3,772 €2,568 -€1,204 -31.9%
Profit (loss) for the period before taxes 9903 -€202,102 -€98,995 +€103,107 +51.0%
Profit (loss) for the period 9904 -€202,102 -€98,995 +€103,107 +51.0%
Profit (loss) for the period to be appropriated 9905 -€202,102 -€98,995 +€103,107 +51.0%

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 18 October 2026 via checked.be.